Study investigator David Berg explains why volume overload shouldn't decide which hospitalized patients get an SGLT2 inhibitor.
|Videos|October 5, 2016
Overcoming High Copays to Improve Drug Adherence
Author(s)Lauren Santye, Assistant Editor
Rebekah L. Hanson, PharmD, BCPS, BCACP, clinical pharmacist and assistant professor at the UIC College of Pharmacy, discusses the challenge of out-of-pocket spending and the impact on drug adherence.
Advertisement
Rebekah L. Hanson, PharmD, BCPS, BCACP, clinical pharmacist and assistant professor at the UIC College of Pharmacy, discusses the challenge of out-of-pocket spending and the impact on drug adherence.
Advertisement
Related to this article
With changes in Medicaid eligibility looming, hospitals must plan now to keep patient care gaps at bay.
Advertisement
Advertisement
Trending on Pharmacy Times
1
New Data Reshapes Nonstatin Lipid Therapy Choices
2
Dapagliflozin in Heart Failure: Congestion Isn't the Gatekeeper
3
Ambulatory Pharmacists Convene in Boston at NEIAP's 2026 Annual Forum
4
Semaglutide Linked to Up to 40% Fewer Asthma Attacks, Real-World Data Show
5